-transparent.png){kind=logo}
A series of 2-arylidene-1-indanones, 1, had been shown previously to display cytotoxic properties towards Molt 4/C8, CEM and L1210 cells. In the present study, two series of analogues of 1 were prepared namely various 2-arylidene-1,3-indandiones, 2, and chalcones, 3. In general, the potencies of compounds 2 and 3 were greater than the analogues bearing the same aryl substituents in series 1. Molecular modeling was undertaken in order to seek explanations for the variation in bioactivities.
Related Publications
Hari N Pati, and
Umashankar Das, and
Erik De Clercq, and
Jan Balzarini, and
Jonathan R Dimmock
August 2003,
Journal of enzyme inhibition and medicinal chemistry,
Hari N Pati, and
Umashankar Das, and
Erik De Clercq, and
Jan Balzarini, and
Jonathan R Dimmock
November 2015,
Organic letters,
Hari N Pati, and
Umashankar Das, and
Erik De Clercq, and
Jan Balzarini, and
Jonathan R Dimmock
April 1973,
Die Pharmazie,
Hari N Pati, and
Umashankar Das, and
Erik De Clercq, and
Jan Balzarini, and
Jonathan R Dimmock
January 2018,
Anti-cancer agents in medicinal chemistry,
Hari N Pati, and
Umashankar Das, and
Erik De Clercq, and
Jan Balzarini, and
Jonathan R Dimmock
March 1979,
Anesthesiology,
Hari N Pati, and
Umashankar Das, and
Erik De Clercq, and
Jan Balzarini, and
Jonathan R Dimmock
February 2003,
European journal of medicinal chemistry,
Hari N Pati, and
Umashankar Das, and
Erik De Clercq, and
Jan Balzarini, and
Jonathan R Dimmock
May 1975,
Archiv der Pharmazie,
Hari N Pati, and
Umashankar Das, and
Erik De Clercq, and
Jan Balzarini, and
Jonathan R Dimmock
October 2021,
Archiv der Pharmazie,
Hari N Pati, and
Umashankar Das, and
Erik De Clercq, and
Jan Balzarini, and
Jonathan R Dimmock
February 2004,
Journal of enzyme inhibition and medicinal chemistry,
Hari N Pati, and
Umashankar Das, and
Erik De Clercq, and
Jan Balzarini, and
Jonathan R Dimmock
November 1964,
Journal of medicinal chemistry,
